FDA MedWatch: CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch: CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses

CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses

AUDIENCE: Eye Care, Consumers

ISSUE: The unintended presence of a silicone oil residue on lenses from certain lots of Avaira Toric contact lenses.  Symptoms may range from hazy, blurry vision, discomfort to eye injuries requiring medical treatment. 
BACKGROUND:  Used for the correction of nearsightedness or farsightedness with astigmatism in persons who may or may not have had their natural lens of their eye removed and who has not had previous eye diseases with a lens powers from -20.00 to +20.00 diopters and astigmatic corrections from -0.25 to -10.00 diopters.  The AVAIRA Soft Contact Lens is indicated for single-use disposable wear and daily wear.  When prescribed for frequent replacement, the lens may be disinfected using a chemical or hydrogen peroxide disinfecting system.
On August 19, 2011, the firm sent a recall notification letter to the US and Canadian distributors and health care practitioners. These lenses were manufactured from November 1, 2010 through August 3, 2011.  Approximately 778,301 lenses were distributed.
RECOMMENDATION: Consumers should return their lenses to their eye care practitioner if they have the affected contact lenses.  In addition, if a consumer who is wearing Avaira Toric contact lenses and experiences any symptoms, it is recommended that they stop wearing the lenses immediately and contact their eye care practitioner for advice.
     Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

[10/14/2011 - Recall Notice - FDA]


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux